Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3754656019 | Inotersen (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3754657011 | Inotersen | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Inotersen | Is a | Transthyretin synthesis inhibitor | true | Inferred relationship | Some | ||
| Inotersen | Has disposition | Transthyretin synthesis inhibitor | true | Inferred relationship | Some | ||
| Inotersen | Is a | Antisense oligonucleotide | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Inotersen-containing product | Has active ingredient | True | Inotersen | Inferred relationship | Some | 1 |
| Inotersen only product | Has active ingredient | True | Inotersen | Inferred relationship | Some | 1 |
| Inotersen only product in parenteral dose form | Has active ingredient | True | Inotersen | Inferred relationship | Some | 1 |
| Inotersen-containing product in parenteral dose form | Has active ingredient | True | Inotersen | Inferred relationship | Some | 1 |
| Inotersen (as inotersen sodium) 189.333 mg/mL solution for injection | Has BoSS | True | Inotersen | Inferred relationship | Some | 1 |
| Inotersen sodium | Is modification of | True | Inotersen | Inferred relationship | Some |
Reference Sets
Substance foundation reference set
FHIR